Table of Content

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 24
1.2.2 MARKETS COVERED 25
FIGURE 1 UROLOGY DEVICES MARKET SEGMENTATION 25
1.2.3 YEARS CONSIDERED FOR THE STUDY 26
1.3 CURRENCY 26
1.4 LIMITATIONS 26
1.5 STAKEHOLDERS 26
1.6 SUMMARY OF CHANGES 27

2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.2 RESEARCH APPROACH 28
FIGURE 2 UROLOGY DEVICES MARKET: RESEARCH DESIGN 28
2.2.1 SECONDARY DATA 29
2.2.1.1 Key data from secondary sources 29
2.2.2 PRIMARY DATA 30
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 31
2.3 MARKET SIZE ESTIMATION 31
2.3.1 BOTTOM-UP APPROACH 32
FIGURE 4 UROLOGY DEVICES MARKET: BOTTOM-UP APPROACH 32
2.3.2 TOP-DOWN APPROACH 33
FIGURE 5 UROLOGY DEVICES MARKET: TOP-DOWN APPROACH 33
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 34
FIGURE 6 DATA TRIANGULATION METHODOLOGY 34
2.5 ASSUMPTIONS FOR THE STUDY 35

3 EXECUTIVE SUMMARY 36
FIGURE 7 UROLOGY DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 36
FIGURE 8 UROLOGY DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 37
FIGURE 9 UROLOGY DEVICES MARKET, BY END USER, 2021 VS. 2026 (USD MILLION) 37
FIGURE 10 UROLOGY DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION) 38
?

4 PREMIUM INSIGHTS 39
4.1 UROLOGY DEVICES MARKET OVERVIEW 39
FIGURE 11 RISING PREVALENCE OF UROLOGICAL CONDITIONS TO DRIVE MARKET GROWTH 39
4.2 UROLOGY INSTRUMENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 40
FIGURE 12 DIALYSIS DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026 40
4.3 UROLOGY ENDOSCOPES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 41
FIGURE 13 LAPAROSCOPES SEGMENT DOMINATES THE MARKET IN 2021 41
4.4 UROLOGY DEVICES MARKET SHARE, BY END USER, 2021 VS. 2026 41
FIGURE 14 HOSPITALS, ASCS, & CLINICS ARE THE LARGEST END USERS OF UROLOGY DEVICES 41
4.5 UROLOGY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 42
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE UROLOGY DEVICES MARKET DURING THE FORECAST PERIOD 42

5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
FIGURE 16 UROLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 43
5.2.1 DRIVERS 44
5.2.1.1 Rising incidence and prevalence of urological conditions 44
TABLE 1 GLOBAL PREVALENCE OF URINARY INCONTINENCE 44
TABLE 2 GLOBAL UROLOGIC CANCER INCIDENCE 45
TABLE 3 GLOBAL INCIDENCE & PREVALENCE OF PROSTATE CANCER 45
5.2.1.2 Growing preference for minimally invasive procedures 45
5.2.1.3 Growing number of hospitals and investments in endoscopy and laparoscopy facilities 46
5.2.2 RESTRAINTS 46
5.2.2.1 High degree of consolidation 46
5.2.2.2 High cost of urology devices 47
5.2.3 OPPORTUNITIES 47
5.2.3.1 Emerging markets offer lucrative opportunities 47
5.3 IMPACT OF COVID-19 ON THE UROLOGY DEVICES MARKET 48
5.4 PRICING ANALYSIS 48
TABLE 4 PRICES OF UROLOGY DEVICES (2020) 48
5.5 PATENT ANALYSIS 49
5.6 VALUE CHAIN ANALYSIS 49
FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE 50
5.7 SUPPLY CHAIN ANALYSIS 50
FIGURE 18 DISTRIBUTION?A STRATEGY PREFERRED BY PROMINENT COMPANIES 51
5.8 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET 52
FIGURE 19 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET 52
5.9 PORTER’S FIVE FORCES ANALYSIS 53
FIGURE 20 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS 53
5.9.1 THREAT OF NEW ENTRANTS 53
5.9.2 THREAT OF SUBSTITUTES 53
5.9.3 BARGAINING POWER OF BUYERS 54
5.9.4 BARGAINING POWER OF SUPPLIERS 54
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.10 PESTLE ANALYSIS 54
5.11 REGULATORY LANDSCAPE 55
5.11.1 NORTH AMERICA 55
5.11.1.1 US 55
5.11.1.2 Canada 55
5.11.2 EUROPE 55
5.11.3 ASIA PACIFIC 56
5.11.3.1 China 56
5.11.3.2 Japan 56
5.11.3.3 India 56
5.11.3.4 South Korea 56
5.11.4 LATIN AMERICA 56
5.11.4.1 Brazil 57
5.11.4.2 Mexico 57
5.11.5 MIDDLE EAST 57
5.11.6 AFRICA 58
5.12 TRADE ANALYSIS 58
5.12.1 TRADE ANALYSIS FOR DIALYSIS INSTRUMENTS 58
5.12.1.1 Import data for dialysis instruments, by country,
2016?2020 (USD Million) 58
5.12.2 TRADE ANALYSIS FOR ENDOSCOPES 58
5.12.2.1 Import data for endoscopes, by country, 2016?2020 (USD Million) 58

6 UROLOGY DEVICES MARKET, BY PRODUCT 59
6.1 INTRODUCTION 60
TABLE 5 UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 60
6.2 INSTRUMENTS 60
TABLE 6 UROLOGY INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 60
TABLE 7 UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 61
6.2.1 DIALYSIS DEVICES 61
TABLE 8 DIALYSIS DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 62
TABLE 9 DIALYSIS DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 62
6.2.1.1 Hemodialysis devices 62
6.2.1.1.1 HHD has gained significance due to improved clinical outcomes for patients 62
?
TABLE 10 HEMODIALYSIS DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 63
6.2.1.2 Peritoneal dialysis devices 63
6.2.1.2.1 Technological advancements in PD devices and increasing product approvals to propel market growth 63
TABLE 11 PERITONEAL DIALYSIS DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 64
6.2.2 ENDOSCOPES 64
TABLE 12 ENDOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 65
TABLE 13 ENDOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION) 65
6.2.2.1 Laparoscopes 65
6.2.2.1.1 Growing number of laparoscopy procedures to support the market growth 65
TABLE 14 LAPAROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 66
6.2.2.2 Ureteroscopes 66
6.2.2.2.1 Continuous technological advancements to support the growth of this market 66
TABLE 15 URETEROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 67
6.2.2.3 Nephroscopes 67
6.2.2.3.1 High cost of maintenance to restrain the market growth 67
TABLE 16 NEPHROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 68
6.2.2.4 Resectoscopes 68
6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to drive the demand for resectoscopes 68
TABLE 17 RESECTOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 69
6.2.2.5 Cystoscopes 69
6.2.2.5.1 Increasing prevalence and incidence of urological cancers to drive the uptake to cystoscopes for early diagnosis and treatment 69
TABLE 18 CYSTOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION) 70
6.2.3 LASER & LITHOTRIPSY DEVICES 70
6.2.3.1 Increasing prevalence of kidney diseases to support market growth 70
TABLE 19 LASER & LITHOTRIPSY DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 71
6.2.4 ENDOVISION & IMAGING SYSTEMS 71
6.2.4.1 Need for high-resolution images for better observation of body cavities and organs to propel the market in the coming years 71
TABLE 20 ENDOVISION & IMAGING SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 73
6.2.5 ROBOTIC SYSTEMS 73
6.2.5.1 Growing industry-academia collaborations to support market growth 73
TABLE 21 ROBOTIC SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 74
6.2.6 INSUFFLATORS 74
6.2.6.1 Increasing volume of laparoscopic procedures to boost the demand for insufflators 74
TABLE 22 INSUFFLATORS MARKET, BY REGION, 2019–2026 (USD MILLION) 74
6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS 75
6.2.7.1 Growing incidence of chronic diseases to drive the market growth 75
TABLE 23 ENDOSCOPY FLUID MANAGEMENT SYSTEMS MARKET, BY REGION,
2019–2026 (USD MILLION) 75
6.2.8 URODYNAMIC SYSTEMS 76
6.2.8.1 Growing patient pool to support the growth of this product segment 76
TABLE 24 URODYNAMIC SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 76
6.3 CONSUMABLES & ACCESSORIES 77
TABLE 25 UROLOGY CONSUMABLES & ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 77
TABLE 26 UROLOGY CONSUMABLES & ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 77
6.3.1 DIALYSIS CONSUMABLES 78
6.3.1.1 Growing number of dialysis procedures to support market growth 78
TABLE 27 DIALYSIS CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION) 78
6.3.2 CATHETERS 79
6.3.2.1 High prevalence of urinary incontinence will drive the market for catheters 79
TABLE 28 CATHETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 79
6.3.3 GUIDEWIRES 80
6.3.3.1 Development of next-generation hybrid guidewires has created significant growth opportunities 80
TABLE 29 GUIDEWIRES MARKET, BY REGION, 2019–2026 (USD MILLION) 80
6.3.4 RETRIEVAL DEVICES & EXTRACTORS 81
6.3.4.1 Technological advancements to support market growth 81
TABLE 30 UROLOGY DEVICES MARKET FOR RETRIEVAL DEVICES & EXTRACTORS,
BY REGION, 2019–2026 (USD MILLION) 81
6.3.5 SURGICAL DISSECTORS, FORCEPS, & NEEDLE HOLDERS 82
6.3.5.1 Growing number of urology procedures to support market growth 82
TABLE 31 SURGICAL DISSECTORS, FORCEPS, & NEEDLE HOLDERS MARKET,
BY REGION, 2019–2026 (USD MILLION) 82
6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS 82
6.3.6.1 Growing demand for effective endoscopic management of ureteral and renal calculi to support market growth 82
TABLE 32 DILATOR SETS & URETHRAL ACCESS SHEATHS MARKET, BY REGION,
2019–2026 (USD MILLION) 83
6.3.7 STENTS 83
6.3.7.1 Growing prevalence of urological and kidney-related disorders to propel market growth 83
TABLE 33 STENTS MARKET, BY REGION, 2019–2026 (USD MILLION) 84
6.3.8 BIOPSY DEVICES 84
6.3.8.1 High incidence of prostate cancer to drive the uptake of biopsy devices 84
TABLE 34 BIOPSY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 85
6.3.9 TUBES & DISTAL ATTACHMENTS 85
6.3.9.1 Growing demand for endoscopy is expected to propel the growth of this segment 85
TABLE 35 TUBES & DISTAL ATTACHMENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 86
6.3.10 DRAINAGE BAGS 86
6.3.10.1 Risk of urinary tract infections and skin irritation to restrain the market growth 86
TABLE 36 DRAINAGE BAGS MARKET, BY REGION, 2019–2026 (USD MILLION) 87
6.3.11 OTHER CONSUMABLES & ACCESSORIES 87
TABLE 37 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 88

7 UROLOGY DEVICES MARKET, BY APPLICATION 89
7.1 INTRODUCTION 90
TABLE 38 UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 90
7.2 KIDNEY DISEASES 90
7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO SUPPORT MARKET GROWTH 90
TABLE 39 UROLOGY DEVICES MARKET FOR KIDNEY DISEASES, BY REGION,
2019–2026 (USD MILLION) 91
7.3 UROLOGICAL CANCER & BPH 91
7.3.1 RISING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE THE MARKET GROWTH 91
TABLE 40 UROLOGY DEVICES MARKET FOR UROLOGICAL CANCER & BPH, BY REGION, 2019–2026 (USD MILLION) 92
7.4 PELVIC ORGAN PROLAPSE 92
7.4.1 HIGH COSTS INVOLVED IN SURGERIES & HIGH REOCCURRENCE RATES TO RESTRAIN THE MARKET GROWTH 92
TABLE 41 UROLOGY DEVICES MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION, 2019–2026 (USD MILLION) 93
7.5 OTHER APPLICATIONS 93
TABLE 42 UROLOGY DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 94

8 UROLOGY DEVICES MARKET, BY END USER 95
8.1 INTRODUCTION 96
TABLE 43 UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 96
8.2 HOSPITALS, ASCS, & CLINICS 96
8.2.1 HOSPITALS, ASCS, & CLINICS ARE THE LARGEST END USERS OF UROLOGY DEVICES 96
TABLE 44 UROLOGY DEVICES MARKET FOR HOSPITALS, ASCS, & CLINICS, BY REGION, 2019–2026 (USD MILLION) 97
8.3 DIALYSIS CENTERS 98
8.3.1 CHANGING REIMBURSEMENT POLICIES IN DEVELOPED COUNTRIES TO RESTRAIN THE MARKET GROWTH 98
TABLE 45 NUMBER OF DIALYSIS CENTERS IN THE US, BY COMPANY, 2019 98
TABLE 46 NUMBER OF DIALYSIS CENTERS IN CHINA, 2018 98
TABLE 47 UROLOGY DEVICES MARKET FOR DIALYSIS CENTERS, BY REGION,
2019–2026 (USD MILLION) 99
8.4 HOME CARE SETTINGS 99
8.4.1 IMPROVED PATIENT OUTCOMES AND SHORTER HOSPITAL STAYS TO SUPPORT MARKET GROWTH 99
TABLE 48 UROLOGY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION,
2019–2026 (USD MILLION) 100

9 UROLOGY DEVICES MARKET, BY REGION 101
9.1 INTRODUCTION 102
TABLE 49 UROLOGY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 102
9.2 NORTH AMERICA 102
FIGURE 21 NORTH AMERICA: UROLOGY DEVICES MARKET SNAPSHOT 103
TABLE 50 NORTH AMERICA: UROLOGY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
TABLE 51 NORTH AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 104
TABLE 52 NORTH AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 104
TABLE 53 NORTH AMERICA: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 105
9.2.1 US 105
9.2.1.1 The US dominates the North American urology devices market 105
TABLE 54 US: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 106
TABLE 55 US: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 106
TABLE 56 US: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 106
TABLE 57 US: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 107
9.2.2 CANADA 107
9.2.2.1 Rising prevalence of target diseases to drive market growth in Canada 107
TABLE 58 CANADA: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 108
TABLE 59 CANADA: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 108
TABLE 60 CANADA: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 108
TABLE 61 CANADA: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 109
9.3 EUROPE 109
TABLE 62 EUROPE: UROLOGY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 63 EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 110
TABLE 64 EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 110
TABLE 65 EUROPE: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 111
9.3.1 GERMANY 111
9.3.1.1 Germany to dominate the European urology devices market during the forecast period 111
TABLE 66 GERMANY: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 111
TABLE 67 GERMANY: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 112
TABLE 68 GERMANY: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 112
TABLE 69 GERMANY: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 112
9.3.2 UK 113
9.3.2.1 Rising incidence of kidney conditions to drive market growth in the UK 113
TABLE 70 UK: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 113
TABLE 71 UK: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 72 UK: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 114
TABLE 73 UK: UROLOGY DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 114
9.3.3 FRANCE 115
9.3.3.1 Favorable government initiatives are supporting the market growth in France 115
TABLE 74 FRANCE: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 115
TABLE 75 FRANCE: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 116
TABLE 76 FRANCE: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 116
TABLE 77 FRANCE: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 116
9.3.4 ITALY 117
9.3.4.1 Favorable medical and healthcare reimbursements are driving the market growth in Italy 117
TABLE 78 ITALY: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 117
TABLE 79 ITALY: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 117
TABLE 80 ITALY: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 118
TABLE 81 ITALY: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 118
9.3.5 SPAIN 118
9.3.5.1 Rising prevalence of CKD in Spain to drive market growth 118
TABLE 82 SPAIN: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 119
TABLE 83 SPAIN: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 119
TABLE 84 SPAIN: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 119
TABLE 85 SPAIN: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 120
9.3.6 REST OF EUROPE 120
TABLE 86 ROE: NUMBER OF CANCER CASES, BY COUNTRY, 2018 120
TABLE 87 ROE: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 121
TABLE 88 ROE: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 121
TABLE 89 ROE: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 121
TABLE 90 ROE: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 122
9.4 ASIA PACIFIC 122
FIGURE 22 ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT 123
TABLE 91 APAC: UROLOGY DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 92 APAC: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 124
TABLE 93 APAC: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 124
TABLE 94 APAC: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 125
9.4.1 CHINA 125
9.4.1.1 China accounts for the largest share of the APAC market 125
TABLE 95 CHINA: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 126
TABLE 96 CHINA: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 126
TABLE 97 CHINA: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 126
TABLE 98 CHINA: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 127
9.4.2 JAPAN 127
9.4.2.1 Favorable regulatory framework in Japan to support the market growth 127
TABLE 99 JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 128
TABLE 100 JAPAN: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 128
TABLE 101 JAPAN: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 129
TABLE 102 JAPAN: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 129
9.4.3 INDIA 129
9.4.3.1 Healthcare infrastructure improvements and implementation of favorable government initiatives to support market growth in India 129
TABLE 103 INDIA: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 130
TABLE 104 INDIA: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 130
TABLE 105 INDIA: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 131
TABLE 106 INDIA: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 131
9.4.4 REST OF ASIA PACIFIC 131
TABLE 107 ROAPAC: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 132
TABLE 108 ROAPAC: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 132
TABLE 109 ROAPAC: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 133
TABLE 110 ROAPAC: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 133
9.5 LATIN AMERICA 133
9.5.1 HIGH PREVALENCE OF CHRONIC CONDITIONS TO DRIVE MARKET GROWTH 133
TABLE 111 LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 134
TABLE 112 LATIN AMERICA: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 135
TABLE 113 LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 135
TABLE 114 LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 135
9.6 MIDDLE EAST & AFRICA 136
9.6.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE THE MARKET GROWTH 136
TABLE 115 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 136
TABLE 116 MIDDLE EAST & AFRICA: UROLOGY INSTRUMENTS MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 117 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 137
TABLE 118 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 137

10 COMPETITIVE LANDSCAPE 138
10.1 OVERVIEW 138
10.2 KEY PLAYER STRATEGIES 139
10.3 MARKET SHARE ANALYSIS 140
FIGURE 23 UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER (2019) 140
10.4 COMPANY EVALUATION QUADRANT 141
10.4.1 LIST OF EVALUATED VENDORS 141
10.4.2 STARS 141
10.4.3 EMERGING LEADERS 141
10.4.4 PERVASIVE PLAYERS 141
10.4.5 PARTICIPANTS 142
FIGURE 24 UROLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 142
10.5 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2019) 143
10.5.1 PROGRESSIVE COMPANIES 143
10.5.2 STARTING BLOCKS 143
10.5.3 RESPONSIVE COMPANIES 143
10.5.4 DYNAMIC COMPANIES 143
FIGURE 25 UROLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2019 144
10.6 COMPETITIVE SCENARIO 145
10.6.1 MARKET EVALUATION FRAMEWORK, 2018-2020 145
10.6.2 PRODUCT LAUNCHES & APPROVALS 145
TABLE 119 KEY PRODUCT LAUNCHES & APPROVALS 145
10.6.3 EXPANSIONS 146
TABLE 120 KEY EXPANSIONS 146
10.6.4 ACQUISITIONS 146
TABLE 121 KEY ACQUISITIONS 146
10.6.5 PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES 147
TABLE 122 KEY PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES 147

11 COMPANY PROFILES 148
11.1 KEY PLAYERS 148
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA 148
FIGURE 26 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2019) 148
11.1.2 BAXTER INTERNATIONAL, INC. 152
FIGURE 27 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2019) 152
11.1.3 BOSTON SCIENTIFIC CORPORATION 155
FIGURE 28 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019) 155
11.1.4 BECTON, DICKINSON AND COMPANY 158
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 158
11.1.5 OLYMPUS CORPORATION 161
FIGURE 30 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020) 161
11.1.6 B. BRAUN MELSUNGEN AG 163
FIGURE 31 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019) 163
11.1.7 STRYKER CORPORATION 166
FIGURE 32 STRYKER CORPORATION: COMPANY SNAPSHOT (2019) 166
11.1.8 INTUITIVE SURGICAL 168
FIGURE 33 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2019) 168
11.1.9 MEDTRONIC PLC 170
FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 170
11.1.10 CARDINAL HEALTH 172
FIGURE 35 CARDINAL HEALTH: COMPANY SNAPSHOT (2020) 172
11.2 OTHER PLAYERS 174
11.2.1 TELEFLEX INCORPORATED 174
FIGURE 36 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2019) 174
11.2.2 KARL STORZ 176
11.2.3 COOK MEDICAL 177
11.2.4 RICHARD WOLF GMBH 179
11.2.5 COMPACTCATH 180
11.2.6 DORNIER MEDTECH 181
11.2.7 NIKKISO CO., LTD. 182
11.2.8 DIALIFE SA 183
11.2.9 MAXER ENDOSCOPY GMBH 184
11.2.10 WELL LEAD MEDICAL CO., LTD. 184
11.2.11 ROCAMED 185
11.2.12 ENDOMED SYSTEMS GMBH 186
11.2.13 AMSINO INTERNATIONAL, INC. 187
11.2.14 MEDISPEC 187
11.2.15 MEDICAL TECHNOLOGIES OF GEORGIA 188
11.2.16 VIMEX SP. Z O. O. 188
11.2.17 BALTON SP. Z O.O. 189
11.2.18 HUNTER UROLOGY 189
11.2.19 RIBBEL INTERNATIONAL LIMITED 190
11.2.20 J & M URINARY CATHETERS, LLC 190
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX 191
12.1 INSIGHTS FROM INDUSTRY EXPERTS 191
12.2 DISCUSSION GUIDE 192
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 195
12.4 AVAILABLE CUSTOMIZATIONS 197
12.5 RELATED REPORTS 197
12.6 AUTHOR DETAILS 198